OLBA HEALTHCARE HOLDINGS, Inc. (2689) AI Stock Analysis

• Market Cap: ¥12.17B
• Dividend Yield: 4%
• Average Volume (3M): 11.32K
• Price to Earnings (P/E): 9.0
• Beta (1Y): 0.32
• Revenue Growth: 3.95%
• EPS Growth: -11.14%
• Country: JP
• Employees: 1,354
• Sector: Healthcare
• Sector Strength: 39
• Industry: Medical - Distribution
• EPS (TTM): 48.04
• Shares Outstanding: 6,250,000
• 10 Day Avg. Volume: 16,490
• 30 Day Avg. Volume: 11,320
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,321.00
• Price Target Upside: 16.22% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 69 Neutral
• Price Target: ¥2,201.00 ▲(10.22%Upside)

OLBA HEALTHCARE HOLDINGS has a strong financial foundation with room for improvement in cash flow management. While the stock is undervalued, technical indicators suggest a cautious outlook. The absence of recent earnings call data and notable corporate events means our analysis relies heavily on financial performance and valuation.

OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model

Company Description

OLBA HEALTHCARE HOLDINGS, Inc. provides various solutions to medical institutions, universities, corporate research institutes, individuals, and long-term care facilities in Japan. The company's medical equipment business engages in the wholesale of artificial joints, pacemakers, coronary stents, steel instruments, and ultrasonic scalpels; and diagnostic imaging equipment, such as MRI and CT to respirators, intraoperative monitors, and surgical lights. It also offers reagents and equipment for genetic research, cell culture, and protein analysis; automatic analyzers for biochemistry, immunity, and blood; and test reagents, as well as undertakes services for DNA analysis in the field of life sciences. The company's Supply Processing and Distribution business provides goods management, information management, and purchase management services. Its Nursing care products business engages in the rental of nursing care equipment; sale of welfare equipment, such as portable toilets and bathing equipment; and operation of long-term care reform, a comfortable stay at home. The company was formerly known as Kawanishi Holdings, Inc. and changed its name to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021. OLBA HEALTHCARE HOLDINGS, Inc. was founded in 1921 and is headquartered in Okayama, Japan.

How the Company Makes Money

OLBA HEALTHCARE HOLDINGS, Inc. generates revenue through various streams, primarily driven by its extensive healthcare services. The company earns a significant portion of its income from providing inpatient and outpatient medical services, which include surgeries, treatments, and consultations. Revenue is also derived from diagnostic services such as imaging and laboratory testing. Additionally, OLBA HEALTHCARE holds strategic partnerships with insurance companies, facilitating a steady flow of insured patients, and collaborates with pharmaceutical companies for the supply of medications and medical devices, further enhancing its revenue streams.

OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	118.56B	110.47B	107.96B	112.98B	107.90B
Gross Profit	13.60B	12.95B	12.50B	11.60B	11.07B
EBITDA	2.83B	2.68B	2.56B	1.94B	1.16B
Net Income	1.50B	1.41B	1.54B	989.37M	326.41M
Balance Sheet
Total Assets	43.24B	40.88B	39.97B	36.56B	33.68B
Cash, Cash Equivalents and Short-Term Investments	2.73B	2.40B	3.19B	2.16B	1.93B
Total Debt	1.63B	1.92B	1.28B	1.96B	3.91B
Total Liabilities	31.86B	30.55B	30.88B	28.43B	26.40B
Stockholders Equity	11.37B	10.33B	9.09B	8.13B	7.28B
Cash Flow
Free Cash Flow	1.61B	-910.52M	1.97B	2.49B	407.07M
Operating Cash Flow	2.08B	-659.52M	2.42B	3.13B	862.56M
Investing Cash Flow	-673.03M	-306.25M	-211.81M	-630.38M	-496.04M
Financing Cash Flow	-1.09B	175.94M	-1.17B	-2.26B	439.89M

OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1997.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Negative. The current price of 1997 is below the 20-day moving average (MA) of 2025.20, below the 50-day MA of 2025.04, and above the 200-day MA of 1964.13, indicating a neutral trend. The MACD of -9.11 indicates Positive momentum. The RSI at 41.23 is Neutral, neither overbought nor oversold. The STOCH value of 9.39 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2689.

OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3417	80 Outperform	¥14.98B	5.61		2.39%	4.42%	20.59%
9265	76 Outperform	¥6.78B	11.00		2.30%	3.06%	-6.60%
4350	73 Outperform	¥15.18B	11.65		2.38%	6.09%	-30.07%
3183	70 Outperform	¥37.95B	18.77		3.93%	11.04%	20.33%
2689	69 Neutral	¥12.17B	8.98		4.00%	3.95%	-11.14%
3151	68 Neutral	¥53.90B	8.04		4.01%	2.19%	30.09%
Sector *	52 Neutral	$7.53B	0.20	-61.87%	2.28%	16.72%	1.10%

OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events

OLBA HEALTHCARE Reports Modest Sales Growth Amid Profit Decline

OLBA HEALTHCARE HOLDINGS, Inc. reported a modest increase in net sales for the nine months ending March 31, 2025, despite a decline in operating and ordinary profits compared to the previous year. The company’s financial position shows a slight increase in total assets and net assets, although the equity ratio decreased. The announcement indicates a stable dividend forecast, with no revisions to the financial results forecast, suggesting a cautious but steady approach to growth and shareholder returns.